Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-24 @ 11:48 PM
NCT ID:
NCT05078151
Eligibility Criteria:
Inclusion Criteria:
* Men 18 or over years old.
* Patients with castration resistant prostate cancer.
* Evidence of bone metastases by any imaging technique.
* Patients due to start treatment with abiraterone or enzalutamide. In the exploratory cohorts, we will include patients due to start treatment with other systemic therapies for advanced prostate cancer (A-taxanes, B-radiopharmaceuticals, C-other therapies).
* Written (signed and dated) informed consent.
Exclusion Criteria:
* Contraindications to MRI.
* Inability of patient to tolerate whole body MRI (e.g. claustrophobia).
* Patients who have received radiotherapy within the last three months and with no bone metastases outside the radiotherapy field.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT05078151
Study Brief:
Protocol Section:
NCT05078151